Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan
- PMID: 38954076
- DOI: 10.1007/s10147-024-02575-3
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan
Abstract
Background: In Japan, comprehensive cancer statistics are collected through cancer registries. However, data on urological cancers are rarely summarized or published in research papers.
Methods: This retrospective study was performed using publicly available statistical data on urological cancers (prostate cancer [PCa], bladder cancer [BCa], and cancers of kidney and urinary tract [except urinary bladder]) in Japan, including a summary of the Ministry's mortality statistics, cancer incidence statistics from the Regional Cancer Registries through 2015, and the National Cancer Registry statistics from 2016. We examined the incidence and mortality rates of urological cancers stratified by age groups.
Results: The number of new cases of PCa, BCa, and cancers of kidney and urinary tract (except urinary bladder) in 2019 was 94,748, 23,383, and 30,458, respectively, and the number of deaths in 2022 was 13,439, 9,598, and 9,795, respectively. The incidence and mortality rates of urological cancers have consistently increased. Since 2000, there has been a noteworthy increase in the mortality rate of urological cancers among individuals aged > 85 years. The incidence and mortality rates of BCa and cancers of kidney and urinary tract (except urinary bladder) were significantly higher in males than in females.
Conclusions: Urological cancers in very elderly patients (> 85 years) will become increasingly important in the future.
Keywords: Bladder; Japan; Kidney; Prostate; Statistics; Urological cancer.
© 2024. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
References
-
- Schafer EJ, Jemal A, Wiese D et al (2023) Disparities and trends in genitourinary cancer incidence and mortality in the USA. Eur Urol 84(1):117–126. https://doi.org/10.1016/j.eururo.2022.11.023 - DOI - PubMed
-
- Tian YQ, Yang JC, Hu JJ et al (2023) Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: systematic analysis for the global burden of disease study 2019. Front Public Health 11:1119374. https://doi.org/10.3389/fpubh.2023.1119374 - DOI - PubMed - PMC
-
- Giona S (2021) The epidemiology of prostate cancer. In: Bott SRJ, Ng KL (eds) Prostate cancer. Brisbane (AU). https://doi.org/10.36255/exonpublications.prostatecancer.epidemiology.2021
-
- Zhai Z, Zheng Y, Li N et al (2020) Incidence and disease burden of prostate cancer from 1990 to 2017: results from the global burden of disease study 2017. Cancer 126(9):1969–1978. https://doi.org/10.1002/cncr.32733 - DOI - PubMed
-
- Zi H, He SH, Leng XY et al (2021) Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil Med Res 8(1):60. https://doi.org/10.1186/s40779-021-00354-z - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
